Loading company…
Pacific GeneTech develops vaccine and adjuvant technologies for veterinary and human health.
Founded in 2009, Pacific GeneTech develops vaccine and adjuvant technologies and operates in the USA, Hong Kong and Canada. Its products include the Aegis vaccine platform and adjuvant systems. In August 2022, it raised USD 10 million from Arkansas Development Finance Authority, FHB Ventures, PT Medion Farma and Whist Subholdings, with company management participating. The funding was intended to advance Aegis and support an Arkansas manufacturing facility, development lab and office.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in